Intuitive Surgical, Inc. $ISRG Shares Sold by GraniteShares Advisors LLC

GraniteShares Advisors LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 80.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 566 shares of the medical equipment provider’s stock after selling 2,351 shares during the quarter. GraniteShares Advisors LLC’s holdings in Intuitive Surgical were worth $321,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Independence Bank of Kentucky raised its holdings in Intuitive Surgical by 2.0% during the fourth quarter. Independence Bank of Kentucky now owns 1,281 shares of the medical equipment provider’s stock worth $726,000 after purchasing an additional 25 shares in the last quarter. RPG Investment Advisory LLC boosted its stake in Intuitive Surgical by 20.5% in the fourth quarter. RPG Investment Advisory LLC now owns 40,752 shares of the medical equipment provider’s stock valued at $23,080,000 after acquiring an additional 6,945 shares in the last quarter. Florida Trust Wealth Management Co grew its stake in Intuitive Surgical by 23.2% during the 4th quarter. Florida Trust Wealth Management Co now owns 4,007 shares of the medical equipment provider’s stock worth $2,269,000 after buying an additional 755 shares during the last quarter. Meridian Investment Counsel Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $213,000. Finally, Signaturefd LLC increased its holdings in shares of Intuitive Surgical by 14.2% in the 4th quarter. Signaturefd LLC now owns 8,455 shares of the medical equipment provider’s stock valued at $4,789,000 after acquiring an additional 1,050 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, SVP Patricia L. Wadors sold 220 shares of the firm’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gary S. Guthart sold 24,500 shares of the business’s stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the completion of the sale, the director owned 3,694 shares in the company, valued at $1,958,189.40. This represents a 86.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 32,943 shares of company stock worth $17,279,568 over the last ninety days. 0.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. Barclays set a $712.00 price target on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, January 26th. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a report on Wednesday, March 11th. The Goldman Sachs Group reiterated a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research note on Friday, January 9th. Piper Sandler reissued an “overweight” rating and set a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. Finally, UBS Group reduced their price objective on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research note on Tuesday, March 17th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $614.95.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $452.07 on Friday. The stock has a market capitalization of $160.54 billion, a price-to-earnings ratio of 57.30, a price-to-earnings-growth ratio of 3.49 and a beta of 1.68. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $603.88. The firm has a 50-day moving average price of $487.43 and a 200 day moving average price of $513.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period last year, the company posted $2.21 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.